bpc-157 regulatory status not approved for human use fda warning panel narrowly backs unapproved peptide drugs favored by RFK Jr. and wellness influencers Patients Using Wellness Peptides Have
Patients Using Wellness Peptides Have No Reliable Information About Wh Exciting news for peptides coming out of today's committee hearing! The FDA Pharmacy Compounding Advisory Committee voted 8 6 to recommend adding BPC 157 to the 503A Bulks List for use in compounding for RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling Health Law Alliance
Pay in 4 interest-free payments of $6.23 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7


